2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 30 | 4.170 | 6.495 | 11.012 | 13.653 | 18.336 |
Total Income - EUR | - | - | - | - | 34 | 4.170 | 6.495 | 11.012 | 15.025 | 18.538 |
Total Expenses - EUR | - | - | - | - | 1.949 | 2.935 | 5.494 | 6.474 | 5.487 | 8.034 |
Gross Profit/Loss - EUR | - | - | - | - | -1.916 | 1.236 | 1.001 | 4.538 | 9.538 | 10.504 |
Net Profit/Loss - EUR | - | - | - | - | -1.916 | 1.111 | 912 | 4.298 | 9.155 | 9.054 |
Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Identique Med S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 2.003 | 2.313 | 1.197 | 1.399 | 1.604 | 1.817 | - | - | - | - |
Current Assets | - | - | - | - | 1.533 | 2.154 | 1.701 | 3.454 | 11.567 | 20.910 |
Inventories | - | - | - | - | 1.481 | 2.049 | 1.582 | 400 | 867 | 0 |
Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 18.811 |
Cash | - | - | - | - | 52 | 105 | 119 | 3.054 | 10.700 | 2.099 |
Shareholders Funds | - | - | - | - | -1.873 | -727 | 199 | 4.493 | 13.662 | 22.674 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 5.224 | 4.484 | 2.900 | 158 | 218 | 239 |
Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8623 - 8623" | |||||||||
CAEN Financial Year | 8623 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.